Literature DB >> 9182211

Decreasing incidence of perinatal Group B streptococcal disease--United States, 1993-1995.

.   

Abstract

Group B streptococcal (GBS) infections are the leading cause of bacterial disease and death among newborns in the United States and an important cause of morbidity among peripartum women and nonpregnant adults with chronic medical conditions. Disease in infants usually presents as sepsis, pneumonia or meningitis but also may include cellulitis or osteomyelitis. In 1990, GBS infections caused an estimated 7600 serious illnesses and 310 deaths among U.S. infants aged < or = 90 days; infections among infants aged < 7 days (i.e., early-onset disease) accounted for approximately 80% of these illnesses. To determine the incidence of GBS disease during 1993-1995, CDC conducted surveillance for this disease in an aggregate population of 12.5 million persons with 190,000 annual live-born infants. This report summarizes the findings of surveillance in this population, which indicate that a statistically significant decline in the incidence of early-onset GBS disease occurred in some surveillance areas.

Entities:  

Mesh:

Year:  1997        PMID: 9182211

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

Review 1.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Detection of group B streptococci in Lim broth by use of group B streptococcus peptide nucleic acid fluorescent in situ hybridization and selective and nonselective agars.

Authors:  Naomi S Montague; Timothy J Cleary; Octavio V Martinez; Gary W Procop
Journal:  J Clin Microbiol       Date:  2008-07-30       Impact factor: 5.948

3.  The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada.

Authors:  H D Davies; J Leblanc; R Bortolussi; A McGeer
Journal:  Paediatr Child Health       Date:  1999-05       Impact factor: 2.253

Review 4.  Laboratory detection of group B Streptococcus for prevention of perinatal disease.

Authors:  F J Picard; M G Bergeron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-16       Impact factor: 3.267

Review 5.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Streptococcus agalactiae pulsed-field gel electrophoresis patterns cross capsular types.

Authors:  P Pillai; U Srinivasan; L Zhang; S M Borchardt; J Debusscher; C F Marrs; B Foxman
Journal:  Epidemiol Infect       Date:  2009-03-04       Impact factor: 2.451

Review 7.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

8.  Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers.

Authors:  Kristina Roloff; Gohar Stepanyan; Guillermo Valenzuela
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

9.  Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.

Authors:  M Quiroga; E Pegels; P Oviedo; E Pereyra; M Vergara
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.